KRAS and gastric cancer: Transduction of oncogenic KRASG12V upregulated spheroid formation ability as well as CD44 and Sox2 expression, leading to the acquisition of cancer stem cell (CSC) phenotypes in wild-type KRAS-expressed GC cells.